News + Filings Transactions Holdings
All 13F 13D/G Other
|
Cherington Charles
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/25/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Eterna Therapeutics Inc.
Txns:
| Bought options to buy
@ $3300000, valued at
$0 Bought 2,307,692 warrants
@ $0.125, valued at
$288.5k
|
|
08/25/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.
Txns:
| Bought 880,195 shares
@ $0.5113, valued at
$450k
Bought 2,200,488 options to buy
@ $0.6135, valued at
$1.3M
|
|
01/06/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.
Txns:
| Bought 743,243 shares
@ $1.23, valued at
$914.2k
Bought 743,243 options to buy
@ $1.23, valued at
$914.2k
|
|
01/06/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/14/2022 |
SC 13D/A
| Cherington Charles reports a 11% stake in Eterna Therapeutics Inc. |
12/06/2022 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Eterna Therapeutics Inc.
Txns:
| Bought 261,756 shares
@ $3.28, valued at
$858.6k
Bought 523,512 warrants
@ $0.125, valued at
$65.4k
|
|
10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/14/2022 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.
Txns:
| Bought 10,481 shares
@ $1.6589, valued at
$17.4k
|
|
09/30/2022 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.
Txns:
| Bought 17,900 shares
@ $1.8702, valued at
$33.5k
|
|
09/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2022 |
3
| Cherington Charles (10% Owner) has filed a Form 3 on Comera Life Sciences Holdings, Inc. |
09/13/2022 |
SC 13D
| Cherington Charles reports a 11.2% stake in Comera Life Sciences Holdings, Inc. |
08/03/2022 |
4
| Cherington Charles (Director) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.
Txns:
| Granted 215,100 options to buy
@ $0.49, valued at
$105.4k
Granted 165,800 options to buy
@ $0.49, valued at
$81.2k
|
|
03/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2021 |
3
| Cherington Charles (Director) has filed a Form 3 on Beard Energy Transition Acquisition Corp. |
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
04/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|